A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $60 to $80

On May 23, major Wall Street analysts update their ratings for $Crinetics(CRNX.US)$, with price targets ranging from $60 to $80.Morgan Stanley analyst Jeffrey Hung maintains with a buy rating, and adj

Futu News20minutes ago

HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $60 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals with a Buy and maintains $60 price target.

Analyst Upgrades06:15

Morgan Stanley Raises Price Target on Crinetics Pharmaceuticals to $70 From $50, Maintains Overweight Rating

Crinetics Pharmaceuticals (CRNX) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $47 to $97.

MT Newswires05:33

Crinetics Pharmaceuticals Inc: Baird raises price target from $52 to $62

Crinetics Pharmaceuticals Inc: Baird raises price target from $52 to $62

Zhitong Finance23:00

Express News | Crinetics Pharmaceuticals Inc : Baird Raises Target Price to $62 From $52

Breakings22:59

Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Lipella Pharmaceuticals, Inc. (LIPO)

TipRanks12:10